Latest Breaking News On - Mitsubishi tanabe pharma group - Page 1 : comparemela.com

Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipeline

Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJeffrey mooreDennis riedlSatpal virdeeCarolyn porterBauke anningaUniversity of dundeeMp healthcare venture management incMitsubishi tanabe pharma groupProf satpal virdeeUbiquitylation unitChief executive officerOutrun therapeuticsVenture managementInvestment director

Sosei and PharmEnable extend neurological disease drugs hunt | Business Weekly | Technology News | Business news

Sosei and PharmEnable extend neurological disease drugs hunt | Business Weekly | Technology News | Business news
businessweekly.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessweekly.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomMatt barnesSosei heptareNeurocrine biosciencesGenentech rocheSosei heptaresMitsubishi tanabe pharma groupJapanese biopharmaPharmenable therapeuticsStructure based drug designHeptares therapeuticsHannah soreVenture management

Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration

Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomSoult ukpyolsiSouth koreaShinichiro nishishitaSosei heptaresGemma mosesSosei heptareErica hollingsworthMatt barnesKentaro taharaMaya bennisonJelena aleksicFrazer hallMedistrava consulting for international mediaTokyo stock exchange

PharmEnable Closes $7 5M Financing led by MP Healthcare to Develop Next Generation of Small Molecule Drugs to Treat Cancer and Neurological Diseases

PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment round of $7.5M to develop the next generation of small molecule drugs against disease areas of high clinical need. The funding round was led by MP Healthcare Venture .

United kingdomSosei heptaresKeith blundyJeffrey mooreChristine martinJonathan milnerUniversity of cambridge enterprise fundCancer research technology ltdKudos pharmaceuticals ltdUniversity of cambridgeParkwalk advisors heyfordInivata ltdMission therapeuticsMillennium pharmaceuticalsMitsubishi tanabe pharma groupCancer research united kingdom

PharmEnable Closes $7 5M Pre-Series Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomJonathan milnerChristine martinSosei heptaresKeith blundyJeffrey mooreUniversity of cambridgeUniversity of cambridge enterprise fundMitsubishi tanabe pharma groupUnited kingdom basedVenture managementCambridge enterpriseCambridge enterprise fundParkwalk advisorsHeyford trustMartlet capital